ScholarIQanswers from OpenAlex

Scleromyxedema: A multicenter study of characteristics, comorbidities, course, and therapy in 30 patients

PaperCitations, authors & open-access status

Scleromyxedema: A multicenter study of characteristics, comorbidities, course, and therapy in 30 patients is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Scleromyxedema: A multicenter study of characteristics, comorbidities, course, and therapy in 30 patients have?

ScholarIQcitation count

Scleromyxedema: A multicenter study of characteristics, comorbidities, course, and therapy in 30 patients has 187 citations in the OpenAlex counts ScholarIQ stores.

When was Scleromyxedema: A multicenter study of characteristics, comorbidities, course, and therapy in 30 patients published?

ScholarIQyear

Scleromyxedema: A multicenter study of characteristics, comorbidities, course, and therapy in 30 patients has 2013 year in the ScholarIQ index.

What is the open-access status of Scleromyxedema: A multicenter study of characteristics, comorbidities, course, and therapy in 30 patients?

ScholarIQoa status

Scleromyxedema: A multicenter study of characteristics, comorbidities, course, and therapy in 30 patients has closed oa status in the ScholarIQ index.

What is the DOI of Scleromyxedema: A multicenter study of characteristics, comorbidities, course, and therapy in 30 patients?

ScholarIQdoi

The DOI for Scleromyxedema: A multicenter study of characteristics, comorbidities, course, and therapy in 30 patients is on the source record.

What is the PMID of Scleromyxedema: A multicenter study of characteristics, comorbidities, course, and therapy in 30 patients?

ScholarIQpmid

The PMID for Scleromyxedema: A multicenter study of characteristics, comorbidities, course, and therapy in 30 patients is on the source record.

What is the OpenAlex record for Scleromyxedema: A multicenter study of characteristics, comorbidities, course, and therapy in 30 patients?

ScholarIQopenalex

The OpenAlex for Scleromyxedema: A multicenter study of characteristics, comorbidities, course, and therapy in 30 patients is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial